24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
23/03/2020
ICN2 and CReSA at the forefront against COVID-19
10/03/2020
Barcelona Synchrotron Park publishes a guide to promote biodiversity in its buildings
27/02/2020
Batteries of the future are investigated in the ALBA synchrotron
10/02/2020
With Solar Orbiter, SENER approaches a star
27/01/2020
Welcome, Natura Bissé!
14/01/2020
The Alba Synchrotron has lots of tricks up its sleeve!